Abstract Objective: Type 1 Diabetes Mellitus is an autoimmune disease which requires
constant care from patients. Continuous Glucose Monitoring (CGM) devices allow to keep …

The technological advances reached in the last years released portable devices with high
computational capabilities and able to overcome the relevant hardware limitations of the …

The aim of control strategies for artificial pancreas systems is to calculate the insulin doses
required by a subject with type 1 diabetes to regulate blood glucose levels by reducing …

An MPC control strategy activated by events is developed, where the event determines
when to perform the control calculation and, therefore, when to apply insulin to the person …

Tight control of blood glucose is a difficult task in patients with type I diabetes. Nowadays,
the artificial pancreas is becoming an auspicious treatment for them. It consists of an insulin …

Recent advancements in CGM sensors (Continuous Glucose Monitoring) and insulin pumps
considerably improved the treatment of diabetes. However, CGM sensors can only measure …

Aujourd'hui, les technologies de mesure CGM (Continuous Glucose Monitoring) et
d'insulinothérapie par pompe à insuline révolutionnent le traitement du diabète. Les …